Facilitating rapid discovery and development of potentially predictive signatures with the most advanced view of immuno-oncology biology.
PanCancer IO 360™ Gene Expression Panel
The PanCancer IO 360 Gene Expression Panel is a unique 770 gene expression panel for research use only (RUO) that combines vital components involved in the complex interplay between the tumor, microenvironment and immune response in cancer allowing for a multifaceted characterization of disease biology and interrogation of mechanisms of immune evasion. Developed specifically for translational research, this powerful new panel incorporates 47 potentially predictive Research Use Only (RUO) biological signatures including the 18-gene Tumor Inflammation Signature as recently described in JCI.1
Translational RUO panel for the research of possible predictive signatures for potential immunotherapy companion diagnostics
Allows for possible identification of responder/non-responder populations for immunotherapy research
Characterize disease biology
Interrogate mechanisms of immune evasion
IO360 Demo Report
Click here to view the demo IO360 report.
Tumor Inflammation Signature
Tumor Inflammation Signature The Tumor Inflammation Signature includes 18 functional genes known to be associated with response to PD-1/PD-L1 inhibitors pathway blockade. Includes 4 Areas of Immune Biology: IFN-ү-responsive genes related to antigen presentation, chemokine expression, cytotoxic activity, and adaptive immune resistance genes.
